Prenatal Screening:
| Test | FTS (First Trimester Screening) | STS (Second Trimester Screening) | Pre-eclampsia Screening |
| Risk assessment for | Down Syndrome (T21), Edwards Syndrome (T18) and Patau Syndrome (T13) | Down Syndrome (T21), Edwards Syndrome (T18) and Neural Tube Defect (NTD) | The occurrence of high blood pressure and presence of protein in the urine during pregnancy |
| When should test |
11-13 weeks 6 days of pregnancy |
15-20 weeks of pregnancy |
11-14 weeks of pregnancy |
| Test requirement(s) | Ultrasound scanning + mother’s blood test | Mother’s blood test | Ultrasound scanning + mother’s blood test + blood pressure |
|
Frequently Asked Question (FAQ): 1. Who should go for FTS and STS? - Advanced maternal age (≥ 35 years old) - Previous birth of a child with a birth defect - Individuals with personal or family history of birth defects - Abnormal ultrasound findings 2. What are the advantages of FTS? - Non-invasive, requires only mother’s blood sample - Safe, no-risk of miscarriage - Accurate, Nuchal Scan + blood test gives 90% accuracy of the result 3. What is pre-eclampsia? - A pregnancy-induced increased blood pressure (hypertension) and protein in the urine (proteinuria), that usually occurs after the 20th weeks of pregnancy, which may severely affect the mother and the fetus. |
.jpg) |
.jpg) |
|
Malaysia
